Articles

Poll

Podcasts

Slideshows

Videos

The sNDA for furosemide seeks to expand the indication to include the treatment of edema due to fluid overload in patients with CKD, with a PDUFA date of March 6, 2025.

FDA Accepts sNDA for Furosemide (Furoscix) in Chronic Kidney Disease

Spigler provides insight into the development of new patient-focused guidelines for managing hyperkalemia in CKD and the importance of providing patients with such resources.

Empowering Patients with Educational Resources for Kidney Disease, with Mike Spigler

The high diagnostic and prognostic application values of newer IgAN machine learning models suggest their eventual utility in clinical practice.

New IgA Nephropathy Machine Learning Models Show Promise for Diagnosis, Prognosis

Neuen explains the cardiovascular and kidney benefits of combining SGLT2 inhibitors and GLP-1 receptor agonists in diabetes and the future of combination therapy.

Brendon Neuen, MBBS, PhD: Optimizing Cardiorenal Prognosis with GLP-1, SGLT2 Combination

The patient-focused guidelines were developed by the American Kidney Fund and AstraZeneca to help people with CKD manage high potassium.

New Hyperkalemia Guidelines Help Patients with CKD Manage, Treat High Potassium

Findings suggest greater CTSS levels are associated with an elevated risk of IgAN and highlight the enzyme’s potential as a diagnostic biomarker.

Elevated Cathepsin S Linked to Increased Risk of IgA Nephropathy

Findings from a meta-analysis examining 12 trials including more than 70,000 patients with diabetes support combining SGLT2 inhibitors and GLP-1 RAs.

SGLT2 Inhibitor, GLP-1 RA Combination Improves Cardiovascular, Kidney Outcomes in Diabetes

Gross hematuria due to infection was not associated with the incidence of gross hematuria due to vaccination in patients with IgAN who received COVID-19 mRNA vaccination.

Vaccine-Related Hematuria in IgA Nephropathy Not Impacted by Infection-Related Hematuria

Patients with chronic tonsillitis had greater IgAN event rates than those without, and further analysis revealed chronic tonsillitis was linked to a greater risk of developing IgAN.

Chronic Tonsillitis Associated with Increased Risk of IgA Nephropathy

Findings highlight the prognostic value of metabolic syndrome components in predicting both renal and cardiovascular outcomes in patients with IgA nephropathy.

Metabolic Syndrome Linked to Renal, Cardiovascular Outcomes in IgA Nephropathy

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Nephrology